|
PRINCIPAL INVESTIGATOR
Bayer Corporation Present
A randomised, double blind, placebo controlled,
multi center, fixed dose, parallel group, 3 month
comparison to investigate the efficacy and safety
of the Phosphodiesterase Type V Inhibitor BAY
38-9456 in males with erectile dysfunction
following radical prostatectomy.
UNIMED Pharmaceutical, Inc Present
An open label, multi center, large community
based study with an 8 week treatment period of
Androgel, a hormone replacement for hypogonadal
men.
Innovative Health Solutions / Pharmacia
Corporation Present
A 12 week, multi centered, naturalistic, open
label, observational study of patients perceptions
and quality of life in patients initiating
overactive bladder therapy with Detrol or patients
changing overactive bladder therapy to Detrol.
SCHERING PLOUGH 1998 - 2000
A national phase 11 trial of Intron, interferon
alfa 2b plus BCG for the treatment of superficial Bladder cancer.
VIVUS Inc 1998 - 1999 Post marketing study to
evaluate the safety and efficacy of MUSE in patients who have failed prior Viagra treatment.
EDUCATION
MD, New York University School of Medicine, New
York, NY. 1984 B.A. University of Pennsylvania,
Philadelphia, PA. 1980
BOARD CERTIFICATION AND LICENSE
American Board of Urology 1992
New YORK State Linense # 162871-1
POST GRADUATE TRAINING
Chief Resident : Urology - New York City 1989 -
1990
New York Medical Center
Bellevue V.A. Medical Center
Manhattan V.A. Medical Center
Memorial Sloan Kettering cancer Center
1988
Urology Resident, New York University Medical
Center 1986 - 1990
PGY - 2, Dep't of Surgery, Monteifiore Medical
Center 1985 - 1986 Intern, Department of Surgery
Monteifiore Medical Center 1984 - 1985
HONORS
The Soifer Award of New York University Medical
Center 1984
Phi Beta Kappa, University of Pennsylvania 1980
Magna Cum Laude, University of Pennsylvania 1980
Dean' List, University of Pennsylvania 1976 -
1980
SOCIETY MEMBERSHIP
American College of Surgeons - Faculty
American Urologic Association, National and New
York Chapters
New York Academy of Medicine - Fellow
New York Medical Society
American Association of Clinical Urology
Society Study of Impotence
ADVISORY COMMITTEES
Pfizer Pharmaceutical _ Speaker Bureau, VIVUS Corp,
NY University.
PUBLICATIONS
Kaminatsky J & Hanna M : Endoscopic treatment
of high grade vesico-uretal reflux using Teflon in
Children with neurogenic bladders, Urology. 1989
Barbara Barlik, MD ; Peter Kaplan, MD ; Jed
Kaminetsky, MD ; George Roentsch, BS, RPH &
James Goldberg, PhD ; Medications with the
potential to enhance sexual responsivity in Women.
1999
Psychiatric Annals 28.1/ January 1999
PRESENTATIONS
Ferdinand Valentine memorial essay contest,
"Endoscopic treatment of high grade vesico,
uretal reflux using teflon in Children with
neurogenic bladders".
Special Note from Les D Power, Managing
Director, Power Health Australia Pty Ltd.
" Dr
Kaminetsky has spent almost a lifetime in the
assistance and caring for Ladies and their welfare.
Not simply from a physically sexual perspective, but
Psychological as well as physiological. Dream
Cream is not simply some way out concoction, boiled up
in the back room. Dream
Cream has come from a devoted, caring and VERY
competent man who has made a lifetime commitment to
this area of Medicine.
His runs are on the board.
I believe Dream Cream is going to help Hundreds of
Thousands of Ladies, worldwide. I believe we will have
a positive & profound impact on relationships
across the world.
"This is our goal". |
